Nanotherapeutics as a localised drug delivery system for the treatment of GBM

Glioblastoma multiforme (GBM) (recently classified by the World Health Organisation as glioblastoma isocitrate dehydrogenase wild-type or mutant), is the most common, malignant brain tumour in adults, mainly due to its rapid proliferation and ability to penetrate and diffusely infiltrate healthy bra...

Full description

Bibliographic Details
Main Author: Vasey, Catherine E
Format: Thesis (University of Nottingham only)
Language:English
Published: 2021
Subjects:
Online Access:https://eprints.nottingham.ac.uk/64137/

Similar Items